We have a trial already with a checkpoint inhibito

We have a trial already with a checkpoint inhibitor which is a type of immunotherapy cancer vaccine.

The trial is in combination partnership with Keytruda (pembrolizumab) in a breast cancer xenograft model.

When Jay spoke it was pretty clear that a paper should come out soon on this trial. Someone correct me if I’m wrong but this is what I gathered when he talked about publishing papers.

Cancer news in this area would be huge. The result should be complete and the results are most likely being published very soon.


https://www.biospace.com/article/embattled-cy...h-tumors-/

Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™

Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )

Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)

Contact FireGate Biotech


— Jeremiah 51:36